EX-23.1 5 urov-ex231_7.htm EX-23.1 urov-ex231_7.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the following the Registration Statements:

(1)

Registration Statement (Form S-8 No. 333-227593) pertaining to the Urovant Sciences Ltd. 2017 Equity Incentive Plan, as amended and restated,

(2)

Registration Statement (Form S-8 No. 333-228386) pertaining to the Urovant Sciences Ltd. 2017 Equity Incentive Plan, as amended and restated,

(3)

Registration Statement (Form S-3 No. 333-234620) of Urovant Sciences Ltd., and

(4)

Registration Statement (Form S-8 No. 333-234621) pertaining to the Urovant Sciences Ltd. 2017 Equity Incentive Plan, as amended and restated and the Urovant Sciences Ltd. 2019 Employee Stock Purchase Plan;

of our report dated June 19, 2020, with respect to the consolidated financial statements of Urovant Sciences Ltd. included in this Annual Report (Form 10-K) of Urovant Sciences Ltd. for the year ended March 31, 2020.

/s/ Ernst & Young LLP

 

Irvine, California

June 19, 2020